Labcorp LH recently announced the expansion of its precision oncology portfolio, which includes new test offerings for solid ...

BioVaxys stands at the forefront of innovation with its mission to develop advanced treatments in oncology, infectious disease, antigen desensitization, allergy, autoimmune diseases, and other immune ...

For those with very severe symptoms suggestive of advanced endometriosis, pelvic magnetic resonance imaging (MRI) can be ...

The researchers found that cervical mucus from Pap smears has a higher cell-free DNA yield than plasma in endometrial cancer cases.

Ernexa Therapeutics’ “Trojan Horse” stem cells can infiltrate ovarian tumors in mice, boosting T cell activity and leading to ...

CK Wang, MD, explains that Black women face higher rates of late-stage breast and ovarian cancer diagnoses, demonstrating the ...

Canadian scientists have identified a promising therapeutic target to attack to prevent breast cancer from recurring: the ...

After FDA approval in late 2023, the non-invasive liver tumor treatment histotripsy has been used at University of Michigan ...

New blood tests can detect cancer recurrence earlier than traditional scans, potentially giving doctors and patients crucial ...

The addition of relacorilant to nab-paclitaxel significantly extended survival for women with platinum-resistant ovarian ...

Brian Slomovitz, MD, of Mount Sinai Medical Center, compares relacorilant plus nab-paclitaxel with existing treatments for platinum-resistant ovarian cancer and highlights the ROSELLA trial’s global ...

Adding dostarlimab to platinum-based chemotherapy and niraparib improved PFS in patients with advanced ovarian cancer.